Press release
Chronic Pain Market is projected to grow to around USD 90 billion by 2034
The global Chronic Pain Market was valued at approximately USD 60 billion in 2024 and is projected to grow to around USD 90 billion by 2034, expanding at a Compound Annual Growth Rate (CAGR) of about 5.5 % between 2025 and 2034. Growth is underpinned by rising prevalence of chronic pain conditions due to aging populations, increased awareness and diagnosis, and ongoing innovation across pharmacologic, device-based, and digital therapies.Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70978
Chronic pain-defined as pain persisting longer than three months-is a complex condition associated with various underlying disorders (e.g., musculoskeletal diseases, neuropathy, cancer pain, arthritis). The market spans analgesic medications, adjunct therapies, neuromodulation and pain management devices, and supportive care services, reflecting broad clinical needs.
Key Market Highlights
• 2024 Market Size: ~USD 60 billion
• 2034 Forecast: ~USD 90 billion
• CAGR (2025-2034): ~5.5 %
• Largest Regional Market: North America
• Primary Growth Drivers: Aging population, rising chronic conditions, innovation in non-opioid and device therapies.
Market Drivers
1. Aging & Chronic Conditions
The global elderly demographic-most susceptible to arthritis, neuropathy, low back and joint pain-continues to expand, fueling long-term chronic pain prevalence and treatment demand.
2. Treatment Innovation
Advances in non-opioid medications, biopharmaceuticals, neuromodulation technologies, and digital pain management solutions broaden therapeutic options beyond traditional analgesics.
3. Increasing Awareness
Greater clinical and patient awareness of pain management strategies, coupled with improved diagnostic screening, increases utilization of pain therapies across healthcare settings.
Segmentation Insights
By Type of Pain
• Nociceptive Pain - Common in arthritis and musculoskeletal conditions
• Neuropathic Pain - Associated with nerve damage and metabolic disorders
• Inflammatory & Other Pain Types include cancer and mixed presentations
These segments reflect the broad range of chronic pain etiologies addressed by therapies.
Therapeutic Classes
• Analgesics (non-opioid & opioid, though shifting toward safer options)
• Antidepressants & Anticonvulsants (especially neuropathic pain)
• Topical & Injectable Pain Modulators
• Non-opioid Drugs & Biologics gaining traction due to safety concerns linked to long-term opioid use.
Routes of Administration
• Oral - Still dominant due to convenience
• Transdermal & Injectable - Growing due to improved sustained action and reduced systemic effects
These delivery innovations help maximize efficacy and patient compliance.
End Users & Channels
• Hospitals - Major share, driven by comprehensive pain programs
• Home Healthcare Settings - Fastest diffusion as telehealth and remote monitoring expand
• Specialty Clinics and Pain Management Centers - Key adopters of multimodal treatments
Distribution is through hospital pharmacies, retail pharmacies, and online pharmacies.
Explore Full Report here: https://exactitudeconsultancy.com/reports/70978/chronic-pain-market
Regional Insights
North America
Dominates the chronic pain market due to high prevalence of pain disorders, strong healthcare infrastructure, advanced therapies, and high public and private healthcare spending.
Europe
Strong market with mature clinical practice and structured pain management guidelines.
Asia Pacific
Fastest-growing, supported by improving healthcare access, rising chronic disease burden, and expanding investment in pain care technologies.
Latin America & Middle East/Africa
Emerging demand tied to increasing access to healthcare and rising awareness of chronic pain management.
Market Challenges
• Regulatory & Safety Pressures due to opioid risks
• Cost & Access Inequities in low-income regions
• Provider Shortages in pain specialty care hamper broad implementation of complex therapies.
Growth Opportunities & Trends
1. Non-Opioid & Advanced Therapies
Strong investment and pipeline activity focus on safer, targeted non-opioid drugs and biologics.
2. Neuromodulation & Device Innovation
Peripheral nerve stimulation and spinal cord stimulation devices, as highlighted by recent industry activity (e.g., expansion of Boston Scientific's portfolio), are reshaping treatment approaches for refractory chronic pain.
3. Digital & Telehealth Solutions
Digital health platforms and telemedicine are improving patient engagement and remote pain monitoring, aligning with broader healthcare digitization trends.
Competitive Landscape
Key global players active in the chronic pain market include major pharmaceutical and device companies such as:
• Pfizer, Johnson & Johnson, Amgen
• GlaxoSmithKline, Novartis, Sanofi
• AbbVie, Teva Pharmaceutical
• UCB S.A. and other specialists in pain therapeutics
These companies are investing in non-opioid options, neuromodulation devices, and integrated chronic pain management solutions to meet evolving clinical and regulatory demands.
Future Outlook (2025-2034)
The chronic pain market is poised for sustained expansion as:
• Population aging increases prevalence of chronic pain disorders
• Non-opioid and advanced therapeutic innovation accelerates
• Telehealth and digital pain management tools expand reach
• Neuromodulation and device-driven therapies gain broader adoption
By 2034, the market is expected to reach approximately USD 90 billion, driven by multi-modal treatment strategies and global demand for effective, safer chronic pain solutions.
This report is also available in the following languages : Japanese (慢性疼痛), Korean (만성 통증), Chinese (慢性疼痛), French (Douleur chronique), German (Chronische Schmerzen), and Italian (Dolore cronico), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/70978
Our More Reports:
Neuropathic Ocular Pain (NOP)â€"Market
https://exactitudeconsultancy.com/reports/72288/neuropathic-ocular-pain-nop-market
Chronic Pain Treatment Market
https://exactitudeconsultancy.com/reports/73148/chronic-pain-treatment-market
Portable Electronic Analgesic Pump Market
https://exactitudeconsultancy.com/reports/74899/portable-electronic-analgesic-pump-market
Smart Cold Therapy Machine Market
https://exactitudeconsultancy.com/reports/75157/smart-cold-therapy-machine-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Pain Market is projected to grow to around USD 90 billion by 2034 here
News-ID: 4311823 • Views: …
More Releases from Exactitude Consultancy
Biliary Tumor Market is projected to reach approximately USD 2.8 billion by 2034 …
Biliary Tumor Market
The Biliary Tumor Market is growing steadily due to rising incidence of bile duct malignancies, increasing demand for advanced diagnostics, and expanding adoption of targeted therapies. The market is estimated at around USD 1.4 billion in 2024 and is projected to reach approximately USD 2.8 billion by 2034, reflecting a CAGR of about 7.2%. Advancements in tumor biology research, improved imaging technologies, and growing awareness of hepatobiliary cancers…
Bile Duct Cancer Market is projected to reach approximately USD 2.4 billion by 2 …
Bile Duct Cancer Market Overview
The Bile Duct Cancer (Cholangiocarcinoma) Market is witnessing steady expansion due to rising global incidence of hepatobiliary cancers, increased adoption of targeted therapies, and advancements in imaging and diagnostic tools. The market was valued at around USD 1.2 billion in 2024 and is projected to reach approximately USD 2.4 billion by 2034, growing at a CAGR of about 7.5% during the forecast period. Increasing awareness, improved…
Urinary Incontinence Devices Market is projected to reach around USD 5.1 billion …
The global Urinary Incontinence Devices Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 5.1 billion by 2034, expanding at a CAGR of about 4.0% from 2024 to 2034. This growth reflects the increasing incidence of urinary incontinence globally-particularly among aging populations-rising awareness of management options, and continued technological advancement in device design and usability.
Download Full PDF Sample Copy of Market Report…
Overt Hepatic Encephalopathy Market is projected to reach nearly USD 3.8 billion …
Overt Hepatic Encephalopathy Market Overview
The Overt Hepatic Encephalopathy Market is expanding due to rising global liver disease prevalence, increasing cirrhosis cases, and the growing need for effective long-term management therapies. The market was valued at around USD 1.7 billion in 2024 and is projected to reach nearly USD 3.8 billion by 2034, registering a CAGR of about 8%. Key growth factors include the increasing adoption of rifaximin therapy, improved…
More Releases for Pain
Comprehensive Pain Management Services Expanded by Denver Pain Management Clinic
Image: https://www.globalnewslines.com/uploads/2025/01/1737464973.jpg
Denver Pain Management Clinic announces expanded services for individuals suffering from chronic pain conditions throughout the Denver metropolitan area. The clinic, established in 2010, continues to strengthen its position as a leading provider of comprehensive pain management services in Colorado through its team of specialized Denver Pain Doctors.
DENVER, CO - October 9, 2025 - Denver Pain Management Clinic [https://denverpainmanagementclinic.com/] announces expanded services for individuals suffering from chronic pain conditions…
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
